Pre-earnings options volume in Heron Therapeutics is normal with calls leading puts :. Implied volatility suggests the market is anticipating a move near 11.6%, or 28c, after results are released. Median move over the past eight quarters is 9.3%.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HRTX:
- Options Volatility and Implied Earnings Moves Today, March 12, 2024
- Heron Therapeutics Inc (HRTX) Q4 Earnings Cheat Sheet
- Biotech Alert: Searches spiking for these stocks today
- Heron Therapeutics Gains FDA Nod for ZYNRELEF® Expansion
- Heron Therapeutics announces FDA approval of ZYNRELEF indication expansion